Clinical Trials Directory

Trials / Completed

CompletedNCT01391676

Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography

Imaging of Blebs After Trabeculectomy With Mitomycin C 0,02% Using the Spectral Domain Optical Coherence Tomography

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Technische Universität Dresden · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is imaging of trabeculectomy blebs regarding structure and function with the spectral domain optical coherence tomography.

Detailed description

After a trabeculectomy with mitomycin C 0,02% for 3 minutes, the blebs are controlled by a glaucoma specialist on day 1, week 1,2,3,4, month 3 and 6 after surgery. The glaucoma specialist will evaluate the bleb appearance according to a standardized protocol. At the same time points the bleb will be imaged with the spectral domain optical coherence tomography, to monitor bleb changes objectively. The investigators hope to see signs of bleb incapsulation and scarring earlier and then treat the patient accordingly.

Conditions

Interventions

TypeNameDescription
PROCEDUREtrabeculectomypostoperative imaging of trabeculectomy blebs with the spectral domain optical coherence tomography

Timeline

Start date
2011-03-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-07-12
Last updated
2013-09-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01391676. Inclusion in this directory is not an endorsement.